Document Detail

Design and rationale of the URGENT Dyspnea study: an international, multicenter, prospective study.
MedLine Citation:
PMID:  18645329     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Dyspnea is a key target in both clinical management and clinical trials of acute heart failure syndromes and its relief important to patients, clinicians, investigators, and regulatory approval agencies. Despite its importance, the impact of early therapy on dyspnea is not well known. The severity of dyspnea may also be influenced by the conditions under which it is measured (ie, sitting up or lying down). URGENT Dyspnea (Ularitide Global Evaluation in Acute Decompensated Heart Failure) is a prospective multicenter study designed to address these issues. METHODS AND RESULTS: Consenting adult patients with dyspnea secondary to acute heart failure syndromes are eligible. Patients must be interviewed within one hour of first physician evaluation, typically in an emergency department or acute care setting, with dyspnea assessed by the patient using both a 5-point Likert scale and 10-point visual analog scale in the sitting (60 degrees) and then supine (20 degrees ) position if symptomatically able. Improvement of dyspnea by change in Likert and visual analog scale scores at 6 h is the primary endpoint. CONCLUSIONS: Timing of dyspnea measurement and the conditions under which it is measured may influence dyspnea severity and this may have significant implications for future acute heart failure syndromes clinical trial design that target dyspnea.
Peter S Pang; Miguel Tavares; Sean P Collins; John G F Cleland; Judd Hollander; Markku Nieminen; Chadwick Miller; D Mark Courtney; J Douglas Kirk; Josep Masip; Alexander Parkhomenko; Cezar Macarie; W Frank Peacock; Jindrich Spinar; Richard Nowak; Dimitar Raev; Alan B Storrow; Vladimir Spisak; Ahmed Hamdy; Alexandre Mebazaa; Mihai Gheorghiade;
Related Documents :
20486829 - Growth hormone and testosterone in heart failure therapy.
11832669 - Difficult cases in heart failure. novel diagnostic markers in heart failure: an emergin...
24184899 - A novel application of guideliner catheter for thrombectomy in acute myocardial infarct...
9258559 - Classification of heart failure in population based research: an assessment of six hear...
23561819 - Neonatal cardiopulmonary bypass.
683909 - The effects of potassium supplements, spironolactone of amiloride on the potassium stat...
1109319 - Return of normal conduction after paroxysmal heart block. report of a case with major d...
17689729 - Qt interval prolongation and torsade de pointes.
19096029 - Gap junction remodeling and spironolactone-dependent reverse remodeling in the hypertro...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of therapeutics     Volume:  15     ISSN:  1536-3686     ISO Abbreviation:  Am J Ther     Publication Date:    2008 Jul-Aug
Date Detail:
Created Date:  2008-07-22     Completed Date:  2008-09-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9441347     Medline TA:  Am J Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  299-303     Citation Subset:  IM    
Department of Emergency Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Disease
Clinical Trials as Topic / methods*
Dyspnea / therapy*
Heart Failure
Multicenter Studies as Topic / methods*
Patient Selection
Prospective Studies
Research Design*
Severity of Illness Index
Time Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pilocarpine for the treatment of refractory dry mouth (xerostomia) associated with botulinum toxin t...
Next Document:  HPV16 and BPV1 infection can be blocked by the dynamin inhibitor dynasore.